<code id='C3B84BDB46'></code><style id='C3B84BDB46'></style>
    • <acronym id='C3B84BDB46'></acronym>
      <center id='C3B84BDB46'><center id='C3B84BDB46'><tfoot id='C3B84BDB46'></tfoot></center><abbr id='C3B84BDB46'><dir id='C3B84BDB46'><tfoot id='C3B84BDB46'></tfoot><noframes id='C3B84BDB46'>

    • <optgroup id='C3B84BDB46'><strike id='C3B84BDB46'><sup id='C3B84BDB46'></sup></strike><code id='C3B84BDB46'></code></optgroup>
        1. <b id='C3B84BDB46'><label id='C3B84BDB46'><select id='C3B84BDB46'><dt id='C3B84BDB46'><span id='C3B84BDB46'></span></dt></select></label></b><u id='C3B84BDB46'></u>
          <i id='C3B84BDB46'><strike id='C3B84BDB46'><tt id='C3B84BDB46'><pre id='C3B84BDB46'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:9
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play
          Eli Lilly buys Point Biopharma in radiopharmaceuticals play

          DarronCummings/APAcouplebillionhere,acouplebillionthere,andprettysoonEliLillyhopesitwillbetalkingabo

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

          MollyFerguson/STATThisweek,apreviewoftheTUDCAstudyinALSandthoughtsonhowitmightimpactAmylyxPharmaceut